Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering CorpfiledCriticalSchering Corp
Priority claimed from PCT/US1996/012538external-prioritypatent/WO1997005896A1/en
Publication of MXPA98001091ApublicationCriticalpatent/MXPA98001091A/es
Publication of MX9801091ApublicationCriticalpatent/MX9801091A/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Una combinacion de interleukina-10 y ciclosporina se utiliza para suprimir la enfermedad injerto contra hospedero, las enfermedades autoinmunes y el rechazo de tejido/injerto. Se ha descubierto que la administracion de una combinacion de interleukina 10 y ciclosporina provoca la supresion sinérgica de la proliferacion de las células T. El uso concurrente de ambos agentes evita la toxicidad asociada con dosis superiores de ciclosporina.
MX9801091A1995-08-091996-08-06Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion.
MX9801091A
(es)